COSTANZO, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 1.465
EU - Europa 1.372
AS - Asia 369
SA - Sud America 4
OC - Oceania 2
Totale 3.212
Nazione #
US - Stati Uniti d'America 1.458
GB - Regno Unito 794
CN - Cina 309
IT - Italia 114
FI - Finlandia 90
DE - Germania 86
SE - Svezia 83
FR - Francia 81
IE - Irlanda 66
TR - Turchia 32
UA - Ucraina 25
BE - Belgio 18
IR - Iran 8
CA - Canada 6
IN - India 6
RU - Federazione Russa 6
KR - Corea 4
NL - Olanda 3
SA - Arabia Saudita 3
BR - Brasile 2
JP - Giappone 2
VN - Vietnam 2
AU - Australia 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
IL - Israele 1
KG - Kirghizistan 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 3.212
Città #
Southend 749
Chandler 226
Jacksonville 226
Woodbridge 214
Ann Arbor 158
Houston 70
Dublin 66
New York 56
Beijing 53
Ashburn 47
Venice 45
Phoenix 44
Nanjing 41
Wilmington 38
Helsinki 31
Jinan 31
Verona 31
Lawrence 30
Princeton 30
Shenyang 24
Düsseldorf 23
Changsha 19
Brussels 18
Hebei 17
Falls Church 14
Ningbo 14
Zhengzhou 13
Jiaxing 12
Tianjin 11
Norwalk 10
Augusta 9
Boardman 9
Haikou 9
Milan 9
Sindelfingen 9
Auburn Hills 8
Hangzhou 8
Mestre 8
Taizhou 8
Guangzhou 7
Redmond 7
Seattle 7
Nanchang 6
Redwood City 6
San Mateo 6
Los Angeles 5
Taiyuan 5
Cleveland 4
San Francisco 4
Seoul 4
Ardabil 3
Chions 3
Dearborn 3
Detroit 3
Elora 3
Fuzhou 3
Leawood 3
Mumbai 3
San Diego 3
Toronto 3
Clearwater 2
Fairfield 2
London 2
Riyadh 2
Tokyo 2
Ahome 1
Amsterdam 1
Andover 1
Antonina 1
Apo 1
Auckland 1
Bishkek 1
Büdelsdorf 1
Cambridge 1
Charlotte 1
Chisinau 1
Delhi 1
Edinburgh 1
Gallipolis 1
Groningen 1
Hanoi 1
Hefei 1
Ijui 1
Kashan 1
Kish 1
Lanzhou 1
Manchester 1
Minsk 1
Mogliano 1
Monmouth Junction 1
Munich 1
Nice 1
Parabiago 1
Philadelphia 1
Reggio Nell'emilia 1
Rome 1
San Jose 1
Shanghai 1
Stockholm 1
Sucre 1
Totale 2.574
Nome #
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 213
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives 156
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 131
Pancreatic cancer stem cells characterization and secretome analysis 130
ISOLATION AND DRUG SENSITIVITY OF CANCER STEM CELLS OBTAINED FROM PANCREATIC ADENOCARCINOMA CELL LINES 126
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells 122
Role of mitochondrial uncoupling protein-2 in cancer cell resistance to gemcitabine 121
Protein synthesis inhibitors cycloheximide and anisomycin induce interleukin-6 gene expression and activate transcription factor NF-kappa-B 120
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. 116
Nuclear factor kappa-B (NF-kappa-B), nuclear factor interleukin-6 (NFIL-6 or C/EBP-beta) and nuclear factor interleukin-6-beta (NFIL6-beta or C/EBP-delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell 113
Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun 113
Cell-specific differences in the regulation of IL-6 expression by PMA 107
Cytotoxicity of Polyspermine-Ribonuclease A and Polyspermine-Dimeric Ribonuclease A 106
Nuclear factor kB, nuclear factor interleukin-6 (NFIL6 or C/EBPbeta) and nuclear factor interleukin-6beta (NFIL6beta or C/EBPdelta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6 expressing human breast carcinoma cell line. 101
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells 100
Protein-DNA interactions in the 5'-flanking region of the bovine pancreatic ribonuclease gene 99
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 99
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 98
Lithostathine messenger RNA expression in different types of chronic pancreatitis. 97
Cross-linked trimers of bovine ribonuclease A: activity on double-stranded RNA and antitumor action 96
Hyaluronic acid-coated liposomes for active targeting of gemcitabine 96
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 94
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 93
Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells 92
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 87
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 82
Inducible nitric oxide synthase expression elicited in the mouse brain by inflammatory mediators circulating in the cerebrospinal fluid 79
"Zero-Length" Dimers of Ribonuclease A: Further Characterization and No Evidence of Cytotoxicity 79
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 73
Sequences related to the ox pancreatic ribonuclease coding region in the genomic DNA of mammalian species 70
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells 13
Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate 12
Totale 3.234
Categoria #
all - tutte 8.347
article - articoli 7.725
book - libri 0
conference - conferenze 622
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.694


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201968 0 0 0 0 0 0 0 0 0 14 32 22
2019/2020367 47 5 3 31 58 39 27 30 25 39 29 34
2020/2021332 69 45 10 27 37 28 7 26 21 5 54 3
2021/2022312 46 61 11 25 15 10 18 18 9 11 29 59
2022/2023638 48 79 56 112 50 129 5 23 65 44 15 12
2023/2024255 13 28 13 43 36 82 2 22 1 15 0 0
Totale 3.234